KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Change in Receivables (2016 - 2025)

Cvs Health (CVS) has disclosed Change in Receivables for 17 consecutive years, with $381.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 244.96% year-over-year to $381.6 billion, compared with a TTM value of $389.1 billion through Dec 2025, up 15480.55%, and an annual FY2025 reading of $389.1 billion, up 29809.92% over the prior year.
  • Change in Receivables was $381.6 billion for Q4 2025 at Cvs Health, up from $3.4 billion in the prior quarter.
  • Across five years, Change in Receivables topped out at $381.6 billion in Q4 2025 and bottomed at -$263.2 billion in Q4 2024.
  • Average Change in Receivables over 5 years is $48.8 billion, with a median of $73.3 billion recorded in 2021.
  • The sharpest move saw Change in Receivables soared 12597.49% in 2023, then crashed 409.09% in 2024.
  • Year by year, Change in Receivables stood at -$206.4 billion in 2021, then surged by 250.99% to $311.7 billion in 2022, then tumbled by 72.67% to $85.2 billion in 2023, then plummeted by 409.09% to -$263.2 billion in 2024, then skyrocketed by 244.96% to $381.6 billion in 2025.
  • Business Quant data shows Change in Receivables for CVS at $381.6 billion in Q4 2025, $3.4 billion in Q3 2025, and $1.1 billion in Q2 2025.